The neuropsychological scores and Functional Activities Questionnaire (FAQ) are significant to measure the cognitive and functional domain of the patients affected by the Alzheimer’s Disease. Further, there are standardized dataset available today that are curated from several centers across the… Continue Reading →

BACKGROUND: Effective and measurable participant recruitment methods are urgently needed for clinical studies in Alzheimer’s disease. OBJECTIVES: To develop methods for measuring recruitment tactics and evaluating effectiveness. METHODS: Recruitment tactics for the Alzheimer’s Disease Neuroimaging Initiative (ADNI3) were measured using… Continue Reading →

The most common dementia worldwide, Alzheimer’s disease is often diagnosed via biomarkers in cerebrospinal fluid, including reduced levels of Aβ1–42, and increases in total tau and phosphorylated tau-181. Here we describe results of a Phase 2a study of a promising… Continue Reading →